receptors, endothelin

Preferred Label : receptors, endothelin;

MeSH definition : Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells.;

MeSH synonym : receptors, endothelium derived vasoconstrictor factor; endothelin receptors; receptors, endothelium-derived vasoconstrictor factor; endothelium derived vasoconstrictor factor receptors; receptors, endothelins; endothelin receptor; receptor, endothelin;

MeSH annotation : DF: RECEPT ENDOTHELIN;

Wikipedia link : https://en.wikipedia.org/wiki/Endothelin receptor;

Is substance : O;

Details

Origin ID

D017466;

UMLS CUI

C0059285;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Endothelin-1 Receptor [NCIt concept]
CISMeF manual mappings
- Substance with endothelin receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-cyano-3,3-diphenylpropionic acid [MeSH Supplementary Concept]
- 2-(2-cyano-5-(pyrid-4-yl)methoxy)phenoxy-2-(2-methyl)phenylacetic acid [MeSH Supplementary Concept]
- 2-(3-fluoro-4-methylphenyl)-4-(2,3-dihydrobenzofuran-5-yl)-1-(N,N-dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid [MeSH Supplementary Concept]
- 2-(benzo(1,3)dioxo-5-yl)-6-isopropyl-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid [MeSH Supplementary Concept]
- 3-(5-(4-benzo(1,3)dioxol-5-yl-2-hydroxy-2-(4-methoxyphenyl)-5-oxo-2,5-dihydrofuran-3-ylmethyl)-2,3-dimethoxyphenoxy)propane-1-sulfonic acid [MeSH Supplementary Concept]
- 4-(2-cyano-5-(3-pyridylmethoxy)phenoxy)-4-(2-methylphenyl)butanoic acid [MeSH Supplementary Concept]
- 7-deacetyl-5-dechloro-1,O(8),8,8a-tetrahydro-7-epi-sclerotiorin [MeSH Supplementary Concept]
- 97-618 compound [MeSH Supplementary Concept]
- A 192621 [MeSH Supplementary Concept]
- A 216546 [MeSH Supplementary Concept]
- ATZ1993 [MeSH Supplementary Concept]
- Atrasentan [MeSH Descriptor]
- BMS 184696 [MeSH Supplementary Concept]
- BMS 184697 [MeSH Supplementary Concept]
- BMS 187308 [MeSH Supplementary Concept]
- BMS 193884 [MeSH Supplementary Concept]
- BQ 238 [MeSH Supplementary Concept]
- BQ 928 [MeSH Supplementary Concept]
- BSF 302146 [MeSH Supplementary Concept]
- Bosentan [MeSH Descriptor]
- CGS 27830 [MeSH Supplementary Concept]
- IRL 1720 [MeSH Supplementary Concept]
- IRL 3461 [MeSH Supplementary Concept]
- J 104132 [MeSH Supplementary Concept]
- J-105859 [MeSH Supplementary Concept]
- L 744453 [MeSH Supplementary Concept]
- LU 224332 [MeSH Supplementary Concept]
- N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,3,3-trimethylbutanamide [MeSH Supplementary Concept]
- N-(6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-5-(4-methylphenyl)-4-pyrimidinyl)-4-tert-butylbenzenesulfonamide [MeSH Supplementary Concept]
- N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide [MeSH Supplementary Concept]
- PD 156252 [MeSH Supplementary Concept]
- PD 161721 [MeSH Supplementary Concept]
- PD 164333 [MeSH Supplementary Concept]
- PD 164800 [MeSH Supplementary Concept]
- RES 1214-1 [MeSH Supplementary Concept]
- RES 1214-2 [MeSH Supplementary Concept]
- RES 701-1 [MeSH Supplementary Concept]
- RES 701-2 [MeSH Supplementary Concept]
- RES 701-3 [MeSH Supplementary Concept]
- RES 701-4 [MeSH Supplementary Concept]
- RPR 111723 [MeSH Supplementary Concept]
- S 0139 [MeSH Supplementary Concept]
- SB 247083 [MeSH Supplementary Concept]
- T 0201 [MeSH Supplementary Concept]
- TBC 2576 [MeSH Supplementary Concept]
- TTA 386 [MeSH Supplementary Concept]
- ZD 1611 [MeSH Supplementary Concept]
- ZD 2574 [MeSH Supplementary Concept]
- cyclo(Trp-Asp-Pro-Val-Leu) [MeSH Supplementary Concept]
- cyclo(tryptophyl-aspartyl-prolyl-isoleucyl-leucyl) [MeSH Supplementary Concept]
- cyclo(tryptophyl-aspartyl-prolyl-valyl-N-methylleucyl) [MeSH Supplementary Concept]
- darusentan [MeSH Supplementary Concept]
- endothelin-1, Ala(10)- [MeSH Supplementary Concept]
- endothelin-1, Ala(9)- [MeSH Supplementary Concept]
- endothelin-1, Cys(Acm)(1,15)-Ala(3)-Leu(7)-Aib(11)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-Cha(19)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-Leu(19)- [MeSH Supplementary Concept]
- endothelin-1, Thr(18)-gamma-methyl-Leu(19)- [MeSH Supplementary Concept]
- enrasentan [MeSH Supplementary Concept]
- isochromophilone III [MeSH Supplementary Concept]
- lysyl-arginyl-12-aminodecanoyl-seryl-prolyl-phenylalanine [MeSH Supplementary Concept]
- ro 46-2005 [MeSH Supplementary Concept]
- ro 48-5695 [MeSH Supplementary Concept]
- sitaxsentan [MeSH Supplementary Concept]
- stachybocin A [MeSH Supplementary Concept]
- stachybocin B [MeSH Supplementary Concept]
- stachybocin C [MeSH Supplementary Concept]
- tezosentan [MeSH Supplementary Concept]
Record concept(s)
- receptors, endothelin [MeSH concept]
Related MeSH Supplementary Concept(s)
- Dear1 protein, mouse [MeSH Supplementary Concept]
- EDNRB protein, human [MeSH Supplementary Concept]
- Ednrb2 protein, xenopus [MeSH Supplementary Concept]
- PD 147953 [MeSH Supplementary Concept]
- PD 147953 [MeSH Supplementary Concept]
- Pael-R protein, drosophila [MeSH Supplementary Concept]
- endothelin protein C receptor, rat [MeSH Supplementary Concept]
- endothelin-3 receptor [MeSH Supplementary Concept]
Related MeSH term(s)
- Endothelin Receptor Antagonists [MeSH Descriptor]
See also
- endothelins [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients